let's hope that the road to approval in Europe will not be as long as it is for Exondys 51
https://musculardystrophynews.com/2018/01/26/ezutromid-reduced-muscle-damage-in-dmd-patients-interim-data-shows/
snad cesta ke schválení v Evropě nebude tak dlouhá jako u Exondys 51
http://www.parentproject.cz/prispevky/ezutromid